CoChat

Increased Atherogenic Lipoproteins are Associated With Cognitive Impairment: Effects of Statins and Subclinical Atherosclerosis

Open access
Carlsson, Cynthia M., Nondahl, David M., Klein, Barbara E. K., McBride, Patrick E., Sager, Mark A., Schubert, Carla R., Klein, Ronald, Cruickshanks, Karen J. · 2009 · Alzheimer Disease & Associated Disorders
Cited by 38

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

Abstract

Hypercholesterolemia increases the risk for dementia. Some studies suggest that statins may protect cognition, but findings are conflicting. Unmeasured confounders, including high-density lipoprotein (HDL) cholesterol or subclinical atherosclerosis, may have influenced prior study outcomes. In older adults participating in a population-based cohort study (n=1711, aged 65 to 97 y), we investigated the relationships of total and HDL cholesterol levels, statin use, and carotid intima-media thickness with the prevalence of cognitive impairment. In adjusted models, participants in the highest quartile of non-HDL (total-HDL) cholesterol had an increased odds of cognitive impairment compared with those in the lowest quartile [odds ratio (OR): 2.06, 95% confidence interval (CI): 1.07-3.98]. Statin use was associated with lower odds of cognitive impairment in unadjusted models (OR: 0.57, 95% CI: 0.36-0.89), but this relationship was not significant after adjusting for vascular and lifestyle factors (OR: 0.84, 95% CI: 0.47-1.49). In this analysis of older adults, increased atherogenic lipoproteins were associated with impaired cognition. Statin use was related to many factors that both negatively and positively affect cognition, but was not associated with better cognitive function. These results suggest that confounding by indication may explain the contradictory findings in studies assessing the association of statins with cognition. Randomized-controlled clinical trials and longitudinal studies are necessary to determine if statins protect against cognitive decline.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/wad.0b013e3181850188

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 38

Metadata

Authors
Carlsson, C. M., Nondahl, D. M., Klein, B. E. K., McBride, P. E., Sager, M. A., Schubert, C. R., Klein, R., & Cruickshanks, K. J.
Venue
Alzheimer Disease & Associated Disorders
Published
2009-01
Volume
23
Issue
1
Pages
11-17
ISSN
0893-0341 (ISSN-L)
OpenAlex
W2024536861
Cited by
38
References
7
FWCI
2.95
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Increased Atherogenic Lipoproteins are Associated With Cognitive Impairment: Effects of Statins and Subclinical Atherosclerosis. https://app.cochat.ai/papers/10.1097/wad.0b013e3181850188
The paper
Carlsson, C. M., Nondahl, D. M., Klein, B. E. K., McBride, P. E., Sager, M. A., Schubert, C. R., Klein, R., & Cruickshanks, K. J. (2009). Increased Atherogenic Lipoproteins are Associated With Cognitive Impairment: Effects of Statins and Subclinical Atherosclerosis. Alzheimer Disease & Associated Disorders. https://doi.org/10.1097/wad.0b013e3181850188

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.